Mitochondria inhibitors help improve effectivness of conventional therapies in chronic myeloid leukemia (CML)
CML shows up on PET scan https://www.ncbi.nlm.nih.gov/pubmed/17885356
This means that regarless of the genetic mutations, there is a good chance it will be sensitive to metabolic treatments such as 2DG.
However, next to glycolisis inhibitors, it may be a good idea to add mitochondrial inhibitors.
According to this PhD thesis, mito inhibitors will improve effectiveness of conventional therapies against CML cancer stem cells http://theses.gla.ac.uk/8615/1/2017KuntzPhD.pdf
Here is a list of mitochondria inhibitors easily accessible https://www.cancertreatmentsresearch.com/a-list-of-mitochondria-inhibitors/ one of which is Metformin.